The interaction of liposomes with the complement system
- PMID: 9523086
The interaction of liposomes with the complement system
Abstract
Activation of complement (C) by haptenized liposomes has been utilized for a long time to study the interaction of biological membranes with C proteins, or as a sensitive immunoassay for the measurement of specific antigens, antibodies, or serum hemolytic C levels. However, it has been increasingly recognized that regardless of antigenicity, C activation is an intrinsic property of all charged phospholipid/cholesterol bilayers. Liposome-induced C activation and its biological consequences show significant interspecies and interindividual variation, and critically depend on the properties of vesicles as well. Activation can proceed through both the classical and the alternative pathways, with or without the involvement of antibodies. The practical significance of the phenomenon is twofold: 1) opsonization of the vesicles promotes their clearance from the circulation and 2) the liberation of C3a and C5a can cause numerous, potentially adverse, biological reactions. In fact, many cardiovascular and hematological changes observed following administration of liposomes in vivo can be explained by C activation; a fact that has not yet gained wide recognition in the field of drug-carrier liposomes.
Similar articles
-
Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production.FASEB J. 2006 Dec;20(14):2591-3. doi: 10.1096/fj.06-6186fje. Epub 2006 Oct 25. FASEB J. 2006. PMID: 17065229
-
Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.Arch Biochem Biophys. 1998 Sep 15;357(2):185-94. doi: 10.1006/abbi.1998.0798. Arch Biochem Biophys. 1998. PMID: 9735159
-
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.Crit Rev Ther Drug Carrier Syst. 2001;18(6):567-606. Crit Rev Ther Drug Carrier Syst. 2001. PMID: 11789676 Review.
-
Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.Transl Res. 2006 Oct;148(4):157-63. doi: 10.1016/j.trsl.2006.05.004. Transl Res. 2006. PMID: 17002917
-
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.Adv Drug Deliv Rev. 2011 Sep 16;63(12):1020-30. doi: 10.1016/j.addr.2011.06.017. Epub 2011 Jul 14. Adv Drug Deliv Rev. 2011. PMID: 21787819 Review.
Cited by
-
Baculoviruses as Vectors for Gene Therapy against Human Prostate Cancer.J Biomed Biotechnol. 2003;2003(2):79-91. doi: 10.1155/S1110724303209049. J Biomed Biotechnol. 2003. PMID: 12721513 Free PMC article.
-
Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.J Nanopart Res. 2011 Jun 1;13(6):2609-2623. doi: 10.1007/s11051-010-0154-5. J Nanopart Res. 2011. PMID: 21779150 Free PMC article.
-
Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent.Circ Cardiovasc Imaging. 2013 Mar 1;6(2):285-94. doi: 10.1161/CIRCIMAGING.112.000119. Epub 2013 Jan 24. Circ Cardiovasc Imaging. 2013. PMID: 23349231 Free PMC article.
-
Magnetic resonance spectroscopy for evaluation of liposome-encapsulated hemoglobin as a resuscitation fluid.Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):69-78. doi: 10.3109/10731191003634638. Artif Cells Blood Substit Immobil Biotechnol. 2010. PMID: 20196685 Free PMC article.
-
Complement activation by phospholipids: the interplay of factor H and C1q.Protein Cell. 2010 Nov;1(11):1033-49. doi: 10.1007/s13238-010-0125-8. Epub 2010 Dec 10. Protein Cell. 2010. PMID: 21153520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources